Skip to main content
. 2025 Sep 25;16:1605717. doi: 10.3389/fphar.2025.1605717

TABLE 4.

Percentage of cell viability of MDAMB-231.

SNo Treatment Conc. in µg/mL % Cell viability
1 ZnONPs 20 79.57 ± 0.003
40 61.04 ± 0.002
60 46.08 ± 0.002
80 34.20 ± 0.004
100 23.51 ± 0.006
2 Cisplatin 15 17.33 ± 0.006
IC50 of ZnONPs = 58.39 μg/mL